Isovolumic loading of the failing heart by intraventricular placement of a spring expander attenuates cardiac atrophy after heterotopic heart transplantation

Biosci Rep. 2018 Jun 27;38(3):BSR20180371. doi: 10.1042/BSR20180371. Print 2018 Jun 29.

Abstract

Cardiac atrophy is the most common complication of prolonged application of the left ventricle (LV) assist device (LVAD) in patients with advanced heart failure (HF). Our aim was to evaluate the course of unloading-induced cardiac atrophy in rats with failing hearts, and to examine if increased isovolumic loading obtained by intraventricular implantation of an especially designed spring expander would attenuate this process. Heterotopic abdominal heart transplantation (HTx) was used as a rat model of heart unloading. HF was induced by volume overload achieved by creation of the aorto-caval fistula (ACF). The degree of cardiac atrophy was assessed as the weight ratio of the heterotopically transplanted heart (HW) to the control heart. Isovolumic loading was increased by intraventricular implantation of a stainless steel three-branch spring expander. The course of cardiac atrophy was evaluated on days 7, 14, 21, and 28 after HTx Seven days unloading by HTx in failing hearts sufficed to substantially decrease the HW (-59 ± 3%), the decrease progressed when measured on days 14, 21, and 28 after HTx Implantation of the spring expander significantly reduced the decreases in whole HW at all the time points (-39 ± 3 compared with -59 ± 3, -52 ± 2 compared with -69 ± 3, -51 ± 2 compared with -71 ± 2, and -44 ± 2 compared with -71 ± 3%, respectively; P<0.05 in each case). We conclude that the enhanced isovolumic heart loading obtained by implantation of the spring expander attenuates the development of unloading-induced cardiac atrophy in the failing rat heart.

Keywords: Cardiac atrophy; heart failure; heterotopic heart transplantation; mechanical heart unloading; spring expander.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / surgery
  • Atrial Natriuretic Factor / genetics
  • Atrial Natriuretic Factor / metabolism
  • Atrophy / metabolism
  • Atrophy / physiopathology
  • Atrophy / prevention & control*
  • Atrophy / surgery
  • Biomarkers / metabolism
  • Disease Models, Animal
  • Equipment Design
  • Fibroblast Growth Factor 2 / genetics
  • Fibroblast Growth Factor 2 / metabolism
  • Fistula
  • Gene Expression
  • Glucose Transporter Type 1 / genetics
  • Glucose Transporter Type 1 / metabolism
  • Heart / physiopathology
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Heart Failure / surgery*
  • Heart Failure / therapy
  • Heart Transplantation*
  • Heart Ventricles / physiopathology
  • Heart Ventricles / surgery*
  • Humans
  • Implants, Experimental
  • Male
  • Rats
  • Rats, Inbred Lew
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / genetics
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
  • Tissue Expansion Devices*
  • Transplantation, Heterotopic
  • Vena Cava, Superior / surgery

Substances

  • Atp2a1 protein, rat
  • Biomarkers
  • Glucose Transporter Type 1
  • Slc2a1 protein, rat
  • Fibroblast Growth Factor 2
  • Atrial Natriuretic Factor
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases